Bridging the Gap Empowering Caregivers With Real Time Access to Aggregate Patient Safety Data Jeffrey M. Ferranti, MD, MS Director, Computerized Patient.

Slides:



Advertisements
Similar presentations
Care Coordination in the Patient-Centered Medical Home New York Academy of Medicine May 24, 2011.
Advertisements

Learning Objectives Understand the Mission of Pharmacy Benefits Management Understand the Background on Pharmacy Re-Engineering Project (PRE) including.
QI, in a nutshell Quality and Safety Educator’s Academy, Society of Hospital Medicine and Georgia McIntosh, MD.
Using Information Technology to Detect Ambulatory Adverse Events Related to Antidiabetic Drug Therapy Judy Wu, PharmD Duke University Hospital Co-Investigators:
March - April 2003 Boston Children’s Hospital e Quality Improvement in an Electronic World Enhanced by Automated Data Extraction & Analysis Denni McColm,
Brian L. Strom, M.D., M.P.H. Chair and Professor, Department of Biostatistics and Epidemiology Director, Center for Clinical Epidemiology and Biostatistics.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
Preventing Medical Errors: Technical, Ethical and Social Issues J.G. Anderson, Ph.D. E.A. Balas, M.D., Ph.D. D.W. Bates, M.D. R.S. Evans, Ph.D. G.J. Kuperman,
The Role of Information Technology For A Private Medical Practice Noel Chua Rosalinda Raymundo.
Patient Safety and Public Health Informatics Iona Thraen, ACSW Patient Safety Director.
Patient Safety Initiatives Kelly Cronin Director, Patient Safety and Outcomes Research Office of Policy and Planning Office of the Commissioner FDA.
Medication Safety Part 2
© Copyright, The Joint Commission Performance Improvement: Getting Started in Your ASC Dana Dunn RN, MBA, CNOR, CASC Certified Yellow Belt Field Representative,
PA - PSRS NGA Center for Best Practices Health Policy Advisors September 10, 2004 Medical Liability & Patient Safety: Pennsylvania’s Experience.
Responsibilities and Principles of Drug Administration
Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.
Survey of Medical Informatics CS 493 – Fall 2004 November 8, 2004 V. “Juggy” Jagannathan.
Meeting Stage 1 Meaningful Use: A View from a Healthcare System Pamela McNutt Sr. VP & CIO Methodist Health System Chair, College of Health Information.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.
Applying New Science to Drug Safety Janet Woodcock, M.D. Acting Deputy Commissioner for Operations April 15, 2005.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
REFERENCES & ACKNOWLEDGMENTS Repurposing Decision Support Data to Detect Prescribing Errors—An Application for Quality Measurement David L. Chin, Ashley.
CLER Pathways II January 28, 2016 PARTNERS IN MEDICAL EDUCATION, INC. Presented by: Tori Hanlon, MS, CHCP GME Consultant.
An Innovative Approach to Medication Management Presenter: Mary Anne Foley, RN, MSN Chief Operating Officer, Jewish Association on Aging AgeWell Pittsburgh.
Smart Pump Wireless Technology: An IQ Boost for the Pump
Medication therapy management
Healthx Analytics: Turning Data Into Actionable Insights
Healthcare and Medicine: New frontiers for analytics and data mining
Constructing a Predictor to Identify Drug and Adverse Event Pairs
The collaborative approach was structured in three phases:
“Quality Improvement – Who Cares?”
Detection & monitoring of ADR
Wireless Access SSID: cwag2017
1 Accredited Southern Group. 2 Accredited Southern Group Quality of Life Group 6: 5 years Strategic Objectives Internal Process Objectives:  Excellence.
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Community Hospital Pharmacy Practice January 29, 2004
Dr Marcello Bertotti Senior Research Fellow
Medication Reconciliation and Reducing Adverse Drug Events
Clinical Pharmacy II.
SNP Alliance Annual Leadership Forum Integrating Policy into Practice
Engaging a Medical Staff to Achieve Higher Value in Cancer Care
Reporting Approaches and Best Practices Jennifer Benjamin NCQA
UT Southwestern Medical Center
Engaging a Microsystem to Reduce 30-Day Readmissions on an Acute Care Unit Erin Johnson, MSN, RN, Sara Stetz, MSN, RN.
Chapter 16 Nursing Informatics: Improving Workflow and Meaningful Use
MDIC- Case for Quality Forum
Drug Induced AKI and NINJA
Strategic Use of Data in Wellness Program Integration
Clinical Alarm Systems - NPSG Goal # 6 -
Electronic Health Information Systems
Therapeutic Drug Management Quality Project
Prescription Drug Monitoring Program
Victoria Gemmell1 Professor Alex Mullen2
Integrating Primary Care & Behavioral Health Care with eConsults: Progress Report on HPHC Quality Grant-funded Project Harvard Pilgrim Health Care 2018.
Chapter 10 Quality and Safety
Prescription Drug Monitoring Program
Robert Graham, MD Acting Deputy Director August 23, 2004
FDA Sentinel Initiative
IMPACT OF PHARMACIST DELIVERED CARE IN THE COMMUNITY PHARMACY SETTING
Tobey Clark, Director*, Burlington USA
Using Your EMR for More than Just Documenting
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Clinical Practice Guidelines: What, Why, Who?
Safety II in a large healthcare system
The Chronic Care Model Overview
Registered Nurse’s Use of HIT, 2006: Findings from a National Survey
Presentation transcript:

Bridging the Gap Empowering Caregivers With Real Time Access to Aggregate Patient Safety Data Jeffrey M. Ferranti, MD, MS Director, Computerized Patient Safety Initiatives Director, Enterprise Data Warehouse Duke University Health System

The Recent IOM Report Preventing Medication Errors (2006) 1 Employ error detection methodologies in all care settings Assess the medication use process through active monitoring Computerized detection of ADEs should complement voluntary reporting “Health care systems should capture information on medication safety and use this information to improve the safety of their care delivery systems.”1 The truth is that over the past 5-7 years our ability to capture electronic information in healthcare has OUTPACED our ability to effectively analyze that information. 1. Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC, National Academy Press, 2006.

Utilizing Data To Facilitate Safety and Quality Efforts IT Safety Systems The Data Warehouse (DSR) Business Intelligence Tools Six Sigma Analytics Performance Services The Balanced Score Card Patient Safety Office Technology We have all of the pieces in place to begin bridging this information gap. We are developing a link between the data from our information systems and operations Operations

Error Monitoring at Duke A Multi Faceted Approach The Qualitative Approach  Safety Reporting (SRS) Provides qualitative data that informs safety and quality initiatives Recently upgraded to SRS 2.0 which standardizes the reporting process Not a reliable metric. The Quantitative Approach  ADE-S Computerized detection of ADEs; Excellent Metric Based on the gold standard of manual chart review Standardized scoring system, published inter-rater reliability

The Qualitative Approach Voluntary Safety Reporting System (SRS) In 2004 we had 23 different ways of reporting safety events at Duke. Today there is 1.

Error Monitoring at Duke A Multi Faceted Approach The Qualitative Approach  Safety Reporting (SRS) Provides qualitative data that informs safety and quality initiatives Recently upgraded to SRS 2.0 to facilitate front line reporting Not a reliable metric. The Quantitative Approach  ADE-S Computerized detection of ADEs; Excellent Metric Based on the gold standard of manual chart review Standardized scoring system, published inter-rater reliability

The Quantitative Approach Computerized ADE Surveillance Database Lab Pharmacy Naranjo Pharmacist Review ADT Orders SI Extensibility : PERIOP / Ambulatory Event Report Generator CDR Possible ADEs to Pharmacist for Review Kappa Daily Reports

Bridging the Gap Duke’s Strategy for Operationalizing Safety Data Empower caregivers with direct access to safety data (COGNOS) Predictive Analytics

OLAP Processing / Data Exploration

Bridging the Gap Duke’s Strategy for Operationalizing Safety Data Empower caregivers with direct access to safety data (COGNOS) Predictive Analytics

ADE-S / SRS Trend Report for Narcotics Transition Period / Surveillance Data Unavailable Serious Adverse Drug Events Reported to The FDA Wall Street Journal / Archives of Internal Medicine Thomas Moore

Y X Six Sigma Opiate Pilot Project Develop a Predicative Risk Model 63,033 Total Patients Exposed to Narcotics 322 Narcotic ADEs SI>=3 Y X Patient Age Patient LOS Patient Gender Clinical Service Morphine (Y/N) Fentanyl (Y/N) Midazalam (Y/N) Etc … Predictive Model- Used recursive partitioning of 63K narcotic exposed patients to uncover “high-risk” (statistically significant) subgroups of pts at higher risk for Opiate ADE; dataset included periop risk factors, opiates, and other interacting medications (SSRIs, benzos, sedatives, etc.);

Six Sigma Opiate Pilot Project Develop a Predictive Risk Model 63,033 322 Narcotic ADEs SI>=3 0.5 % (1/200) Opiate ADE=rare event (0.5%) - Number needed to treat =200 Subgroups of pts at higher risk- Number needed to treat =10 for 10% Allow us to electronically identify pts at higher risk & focus limited resources on these efforts 8.7 % 9.1 % 7.5 % LOS > 4 Days Age > 51 Fentanyl Fluoxetine LOS > 4 Days Age > 51 Fentanyl Scopolamine Thoracic Surgery Any Narcotic Sertraline Midazolam

9.1 % Six Sigma Opiate Project Develop a Predictive Risk Model If we can predict who is at high risk we can target interventions more effectively Acute Pain Consults Increased Monitoring 9.1 % LOS > 4 Days Age > 51 Fentanyl Fluoxetine Limited resources-focus efforts Frequent Re-Assessment Pharmacy Consults

Clinical Information is an Enterprise Asset

Questions